Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

EFFECT OF PHENYLHYDRAZINE DERIVATIVES IN THE TREATMENT OF POLYCYTHEMIA
Perrin H. Long
Perrin H. Long
Published April 1, 1926
Citation Information: J Clin Invest. 1926;2(4):315-328. https://doi.org/10.1172/JCI100048.
View: Text | PDF
Research Article

EFFECT OF PHENYLHYDRAZINE DERIVATIVES IN THE TREATMENT OF POLYCYTHEMIA

  • Text
  • PDF
Abstract

Authors

Perrin H. Long

×

Total citations by year

Year: 2023 2007 2004 1962 1955 1946 1935 1930 Total
Citations: 1 1 1 1 1 1 1 1 8
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (8)

Title and authors Publication Year
Deficiency in hereditary hemorrhagic telangiectasia-associated Endoglin elicits hypoxia-driven heart failure in zebrafish.
Lelièvre E, Bureau C, Bordat Y, Frétaud M, Langevin C, Jopling C, Kissa K
Disease models & mechanisms 2023
Phenylhydrazine haematotoxicity
J Berger
Journal of Applied Biomedicine 2007
Reflecting on 80 years of excellence
U Savla
Journal of Clinical Investigation 2004
Polycythemia
FH Gardner
Disease-a-Month 1962
Das Reticulocytenvolumen
H Weicker, H Fichsel
Klinische Wochenschrift 1955
Treatment of Polycythemia Vera with large Venesections and Plasma Transfusions
G Widström, B Swedberg
Acta Medica Scandinavica 1946
Die Entgiftung des Phenylhydrazins
E Hesse, H Franke, H Hering
Klinische Wochenschrift 1935
Die erythrolytische Komponente des Phenylhydrazin-Hydrochlorids
EV Allen, IH Page
Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie 1930

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts